GMO Strategic Opportunities Alloc III
40 Rowes Wharf Boston MA 02110
Map
Phone: 800-225-5291
| Category: | World Allocation | | Fund Family: | GMO | | Net Assets: | 1.05B | | Year-to-Date Return: | -12.49% | | Yield: | 5.63% | | Morningstar Rating: |  | | Fund Inception Date: | 31-May-05 |
|
Ben Inker
Lead Manager since
31-May-05 | | | Inker is the chief investment officer of quantitative developed equities and director of asset allocation at GMO, which he joined in 1992. Inker holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $10,000,000 | | Min Initial Investment, IRA: | $0 | | Min Initial Investment, AIP: | $0 | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | $0 |
|
| |
| The investment seeks total return greater than its benchmark. The fund intends to expose at least 25% of the assets to fixed income investments and at least 25% of the assets to equity investments. The fund also may be exposed to other U.S. and international equity securities (including both growth and value style equities), U.S. and international fixed income instruments, and securities of companies of any market capitalization. It is a fund of funds. |
| Last Dividend
(8-Jul-08):
| 0.17 | | Last Cap Gain
(8-Jul-08):
| 0.76 | | Annual Holdings Turnover
| 47.00% | | Average for Category:
| 52.20% |
|
| Expense | GBATX | Category
Avg | | Total Expense Ratio: | 0.00%
| 1.20% | | Max 12b1 Fee: | 0.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.38% | | Max Deferred Sales Load: | 0.00%
| 2.39% | | 3 Yr Expense Projection*: |
$199 | $700 | | 5 Yr Expense Projection*: |
$353 | $1,084 | | 10 Yr Expense Projection*: |
$802 | $2,148 |
|
|
11.08% Nasdaq 0.00%
0.24 (1.34%) 
Profile
